The player: 365 game winner Pud Galvin.
His PED: extract of monkey testicles, commercially known as “Brown-Sequard elixir.”
The media reaction:
“if there still be doubting Thomases who concede no virtue of the elixir, they are respectfully referred to Galvin’s record in yesterday’s Boston-Pittsburgh game. It is the best proof yet furnished of the value of the discovery.”
The full story: at Dan Lewis’ wonderful Now I Know, to which you should subscribe. It’s a free daily newsletter which presents cool facts and stories like this one and which will give you a nice and thought-provoking diversion for a few brief minutes every morning.
As for Galvin’s PED: it was likely a placebo. Of course, scientific studies on human growth hormone used by healthy athletes have found the same thing:
There is no current study that has demonstrated a significant increase in workload capacity in response to human GH administration in healthy adults. The studies that have addressed the impact of GH on muscle mass and athletic performance do not show consistently favorable results. For instance, patients with acromegaly do have greater muscle volume than normal individuals, but they do not show an increase in strength or performance. No controlled study to our knowledge has shown a beneficial effect of supraphysiological doses of human GH on muscle strength in trained athletes.
Pud Glavin: proud PED user, enhanced athletically just as much as today’s cursed HGH users but cheered on by the media of his day and inducted into the baseball Hall of Fame.
How much progress we have made!
Free agent right-hander Tim Lincecum isn’t ready to hang up his cleats just yet. At least, that’s the word from Lincecum’s agent, Rick Thurman, who says the 32-year-old is still “throwing and getting ready for the season” (via Andrew Baggarly of the San Jose Mercury News).
Lincecum may not be ready to enter retirement, but another quote from Thurman suggests that he’ll be picky about where he pitches next. He doesn’t appear open to pitching overseas, and despite not having a contract for 2017 (or even any serious suitors), the right-hander is set on pitching in the big leagues this year. Whether or not he’s willing to take a bullpen role to do so remains to be seen.
While Baggarly predicts some interest in the veteran righty, there’s not much in Lincecum’s recent history to inspire faith in him as a starter, or even a reliever. He picked up a one-year, $2.5 million contract with the Angels following his hip surgery in 2015, and went 2-6 in 2016 with a 9.16 ERA, 5.4 BB/9 and 7.5 SO/9 over 38 1/3 innings. At this point, a minor league contract seems like the surest path back to major league success, though he’s unlikely to find an open spot on the Giants’ or Angels’ rosters anytime soon.
Free agent right-hander Jeff Manship has reportedly signed with the NC Dinos of the Korea Baseball Organization, according to FanRag Sports’ Jon Heyman. The righty was non-tendered by the Indians in December.
Manship, 32, completed his second season with Cleveland in 2016. He delivered a 3.12 ERA, 4.6 BB/9 and 7.5 SO/9 rate over 43 1/3 innings, a slight decline after posting an 0.92 ERA with the club the year before. During eight years in the major leagues, Manship carries a 4.82 career ERA, 3.6 BB/9 and 6.4 SO/9 in multiple stints with the Twins, Rockies, Phillies and Indians.
The right-hander will be joined by fellow MLB transplants Eric Hacker and Xavier Scruggs, each of whom took one-year deals with the Dinos last month. Steve Adams of MLB Trade Rumors notes that each KBO team is allowed up to three foreign players, so Manship will round out the trio when he joins the roster. Any salary terms have yet to be disclosed.